Divij Verma - Concepedia

Author

Divij Verma

German Cancer Research Center ORCID

Also Known As

D Verma, D. Verma, Divij Verma, Dr. Dinesh Kumar Verma

Publications

378

Citations

H-Index

Concepts

All Affiliations

German Cancer Research Center Deutschen Konsortium für Translationale Krebsforschung Albert Einstein College of Medicine Heidelberg University Goethe University Frankfurt

About

Divij Verma is an author at German Cancer Research Center specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	163
2	Social Sciences	2	2	64
3	Cell Biology	2	2	63
4	Biochemistry	1	1	33
5	Cellular Physiology	1	1	33

Divij Verma

Publications

274

Citations

H-Index

Page 1

	Year	Citations
Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia Divij Verma, Costanza Zanetti, Parimala Sonika Godavarthy, Leukemia	2020	66
Future directions in preclinical and translational cancer neuroscience research İhsan Ekin Demir, Carmen Mota Reyes, Wasfi Alrawashdeh, Nature Cancer Neuro-oncologyTumor InnervationFuture DirectionsMedicineTranslational Relevance	2020	43
Rat brain endoplasmic reticulum calcium pools are anatomically and functionally segregated. Ajay Verma, Christopher A. Ross, Divij Verma, Cell Regulation -Atpase MrnaCellular NeurobiologyCellular PhysiologySocial SciencesEpendyma	1990	33
Clinically Actionable Strategies for Studying Neural Influences in Cancer İhsan Ekin Demir, Carmen Mota Reyes, Wasfi Alrawashdeh, Cancer Cell Neuro-oncologyTreatment StrategiesTumor InnervationNeurophysiologyActionable Strategies	2020	31
The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia Van T. Hoang, Divij Verma, Parimala Sonika Godavarthy, Leukemia Hematological MalignancyChromatinTranscriptional RegulationDisease OutcomeTranscriptional Regulator Fubp1	2019	30
Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis Divij Verma, Rahul Kumar, Raquel Pereira, Blood	2019	30
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses Courtney D. DiNardo, Divij Verma, Natalia Baran, Nature Cancer MedicineHematologyPhase 1B/2PharmacotherapyGlutaminase Inhibition	2024	26
Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease Huihui Li, Jacob S. Kazmi, Sung Kyun Lee, Blood	2022	15

Page 1